Sartorius Stedim Biotech SA Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL 04-Aug-2021 / 11:14 CET/CEST Dissemination of a French Regulatory News, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement. -----------------------------------------------------------------------------------------------------------------------
Sartorius Stedim Biotech S.A. - 13781 Aubagne Cedex, France
DECLARATION RELATIVE TO
THE NUMBER OF SHARES AND VOTING RIGHTS
MAKING UP THE ISSUED CAPITAL
Article L 233-8-II of the Code of commerce
and article 223-6 of the general regulations of the AMF
Designation of issuer
SARTORIUS STEDIM BIOTECH SA
CS 91051
Z. I. Les Paluds
Avenue de Jouques
13781 Aubagne Cedex
Date of Total number of shares making Total number of theoretical voting rights Total number of net information up the issued capital including treasury shares voting rights
July 31, 92,180,190 160,528,150 160,523,780 2021 ----------------------------------------------------------------------------------------------------------------------- Regulatory filing PDF file File: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL ----------------------------------------------------------------------------------------------------------------------- Language: English Company: Sartorius Stedim Biotech SA
Avenue de Jouques
13781 Aubagne
France Phone: +33 44 284 5600 E-mail: info@sartorius-stedim.com Internet: www.sartorius-stedim.com ISIN: FR0013154002 Euronext DIM Ticker: AMF Category: Total number of voting rights and share capital / Information on the total number of voting rights and
the number of shares making up the share capital EQS News ID: 1223992 End of Announcement EQS News Service -------------------------------------------------------------------------------------
1223992 04-Aug-2021 CET/CEST
Image link: https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=show_t_gif&application_id=1223992&application_name=news
(END) Dow Jones Newswires
August 04, 2021 05:14 ET (09:14 GMT)